Our results demonstrate that RGZ and CGZ inhibit several TGF-β1-induced changes in markers of EMT and lung fibrosis, including cadherin proteins and collagen gene expression, to provide further support for the antifibrotic potential of the thiazolidinedione class of compounds. This evidence concerns the gene TGFB1 and pulmonary fibrosis.